Revolutionizing Stroke Recovery with Pharyngeal Stimulation
In recent guidelines released by leading health organizations, the significance of Phagenyx has been underscored as a vital therapy for stroke recovery. This innovative system focuses on aiding patients in overcoming dysphagia, a common swallowing difficulty experienced post-stroke. The American Heart Association (AHA) and the American Stroke Association (ASA) have included pharyngeal electrical stimulation (PES) in their recommendations, marking a pivotal advancement in stroke management.
Understanding the Role of Phagenyx in Recovery
The Phagenyx system, developed by Phagenesis, is the only commercially available solution that offers PES to patients suffering from dysphagia due to strokes. By applying electrical stimulation to sensory nerves in the throat, this device helps restore the brain's control over swallowing functions, facilitating a quicker recovery from severe swallowing issues. The recent guidelines emphasize the therapeutic value of PES: it may reduce the severity of dysphagia, lower the risk of aspiration, and speed up the decannulation process for patients needing tracheotomy.
Recognizing the Impact of Dysphagia
Dysphagia is a significant complication following a stroke, affecting nearly 45% of stroke survivors. This condition contributes to various serious complications, including a three-fold increase in the risk of pneumonia and seven-fold higher chances of requiring long-term feeding tubes. Furthermore, patients with dysphagia face an eight-fold increase in mortality within three months after a stroke. Dr. H. Alex Choi, an expert in neurology and neurosurgery, highlights the unsettling realities associated with dysphagia, noting its profound impact not just on health, but also on the quality of life for patients.
Key Recommendations from the AHA/ASA Guidelines
The updated AHA/ASA guidelines offer specific recommendations concerning the use of PES for patients with dysphagia. These include:
- The use of PES is recommended to improve dysphagia severity and minimize aspiration risks in patients recovering from strokes.
- For severely affected patients who are mechanically ventilated, treatment with PES post-ventilator weaning can significantly decrease dysphagia severity and facilitate a faster transition away from tracheostomy.
The Future of Dysphagia Treatment
With the inclusion of PES in these guidelines, there is renewed hope for stroke patients facing challenges with swallowing. This validated therapeutic option is a step towards changing how clinicians approach dysphagia in stroke recovery. Dr. Choi asserted that dysphagia should now be viewed as a treatable condition rather than merely a hospital discharge hurdle. This perspective shift demonstrates a commitment to enhancing patient care and improving overall recovery outcomes.
Research Supporting PES Efficacy
Phagenesis’ methods are reinforced by extensive research, featuring over 30 peer-reviewed articles, including nine randomized controlled trials. These studies show that utilizing the Phagenyx system can double the safety of swallowing and significantly lower dysphagia severity scores. As patients experience safer oral intake, the reliance on feeding tubes diminishes, leading to a better quality of life.
Leadership Perspectives on Phagenesis' Achievements
Chad Hoskins, CEO of Phagenesis, expressed pride in the acknowledgment from the AHA. He believes this endorsement not only validates years of dedicated work by clinical partners but also highlights the potential benefits for stroke survivors. By integrating PES into standard stroke care, healthcare providers can tackle dysphagia more effectively, ultimately improving patient experiences.
About Phagenesis
Phagenesis stands at the forefront of medical technology focused on revolutionizing neurogenic dysphagia treatment. The Phagenyx system is a clinically validated therapy that restores efficient swallowing in individuals affected by strokes or other neurological conditions. Its use extends to a variety of situations, demonstrating the versatility and effectiveness of PES in enhancing patients' health and lifestyles. Phagenesis is supported by prominent investors, ensuring continued innovation and research in addressing swallowing difficulties.
Frequently Asked Questions
What is the Phagenyx system?
The Phagenyx system is a neuromodulation therapy that applies pharyngeal electrical stimulation to help restore safe swallowing in stroke patients.
How does PES help stroke patients?
PES aids in the recovery of swallowing control, reduces dysphagia severity, and lowers risks associated with aspiration and feeding tubes.
Why is dysphagia a significant concern for stroke survivors?
Dysphagia can lead to severe complications such as aspiration pneumonia, permanent feeding tube dependence, and increased mortality rates.
What does the new guideline recommend about PES?
The guideline recommends PES as a beneficial treatment for dysphagia in stroke patients, emphasizing its role in routine care.
How is Phagenesis contributing to stroke recovery?
Phagenesis is committed to enhancing stroke recovery by offering innovative treatments like the Phagenyx system backed by robust research and clinical studies.
